FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Device, Hemostasis, Vascular

PMA: P120016 · Supplement: S034 · Decision Jan 3, 2024
Classifications
1
FEI Numbers
33
Registration Numbers
33

Basic Information

Device Name
Device, Hemostasis, Vascular
Trade Name
Cardiva VASCADE Family
PMA Number
P120016
Supplement Number
S034
Device Class
FDA Class 3
Product Code
MGB
Generic Name
Device, hemostasis, vascular
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
January 3, 2024
Date Received
December 5, 2023
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

an additional controlled environment room at the approved Guaymas facility (Sonora, Mexico) for the Cardiva Vascade Family

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MGB Device, Hemostasis, Vascular